These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32249013)

  • 1. Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults.
    Rabin JS; Shirzadi Z; Swardfager W; MacIntosh BJ; Schultz A; Yang HS; Buckley RF; Gatchel JR; Kirn D; Pruzin JJ; Hedden T; Lipsman N; Rentz DM; Black SE; Johnson KA; Sperling RA; Chhatwal JP; ;
    Neurobiol Aging; 2020 Sep; 93():124-130. PubMed ID: 32249013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
    Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
    JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly.
    Hsu DC; Mormino EC; Schultz AP; Amariglio RE; Donovan NJ; Rentz DM; Johnson KA; Sperling RA; Marshall GA;
    J Alzheimers Dis; 2016 Jun; 53(3):1097-105. PubMed ID: 27340843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.
    Chuang YF; An Y; Bilgel M; Wong DF; Troncoso JC; O'Brien RJ; Breitner JC; Ferruci L; Resnick SM; Thambisetty M
    Mol Psychiatry; 2016 Jul; 21(7):910-5. PubMed ID: 26324099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-Specific Association of Lifetime Body Mass Index with Alzheimer's Disease Neuroimaging Biomarkers.
    Lee SH; Byun MS; Lee JH; Yi D; Sohn BK; Lee JY; Kim YK; Shin SA; Sohn CH; Lee DY;
    J Alzheimers Dis; 2020; 75(3):767-777. PubMed ID: 32333586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid burden accelerates white matter degradation in cognitively normal elderly individuals.
    Vipin A; Ng KK; Ji F; Shim HY; Lim JKW; Pasternak O; Zhou JH;
    Hum Brain Mapp; 2019 May; 40(7):2065-2075. PubMed ID: 30604903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life.
    Thirunavu V; McCullough A; Su Y; Flores S; Dincer A; Morris JC; Cruchaga C; Benzinger TLS; Gordon BA
    J Alzheimers Dis; 2019; 69(3):817-827. PubMed ID: 31156169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Subsyndromal Symptomatic Depression with Cognitive Decline and Brain Atrophy in Elderly Individuals without Dementia: A Longitudinal Study.
    Zhang Z; Wei F; Shen XN; Ma YH; Chen KL; Dong Q; Tan L; Yu JT;
    J Affect Disord; 2020 Sep; 274():262-268. PubMed ID: 32469814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-life obesity is a protective factor for prodromal Alzheimer's disease: a longitudinal study.
    Sun Z; Wang ZT; Sun FR; Shen XN; Xu W; Ma YH; Dong Q; Tan L; Yu JT;
    Aging (Albany NY); 2020 Jan; 12(2):2005-2017. PubMed ID: 31986486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain β-Amyloid Links the Association of Change in Body Mass Index With Cognitive Decline in Community-Dwelling Older Adults.
    Buchman AS; Capuano AW; VanderHorst V; Wilson RS; Oveisgharan S; Schneider JA; Bennett DA
    J Gerontol A Biol Sci Med Sci; 2023 Feb; 78(2):277-285. PubMed ID: 34679171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta-positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity.
    Avants BB; Hutchison RM; Mikulskis A; Salinas-Valenzuela C; Hargreaves R; Beaver J; Chiao P;
    Neurobiol Aging; 2019 Feb; 74():191-201. PubMed ID: 30471630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease.
    Bransby L; Lim YY; Ames D; Fowler C; Roberston J; Harrington K; Snyder PJ; Villemagne VL; Salvado O; Masters CL; Maruff P
    J Clin Exp Neuropsychol; 2019 Aug; 41(6):591-600. PubMed ID: 30924399
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.
    Villemagne VL; Pike KE; Darby D; Maruff P; Savage G; Ng S; Ackermann U; Cowie TF; Currie J; Chan SG; Jones G; Tochon-Danguy H; O'Keefe G; Masters CL; Rowe CC
    Neuropsychologia; 2008; 46(6):1688-97. PubMed ID: 18343463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations of Widowhood and β-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults.
    Biddle KD; Jacobs HIL; d'Oleire Uquillas F; Zide BS; Kirn DR; Properzi MR; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
    JAMA Netw Open; 2020 Feb; 3(2):e200121. PubMed ID: 32101313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.